Volpi, N.
(2022).
 Symptomatic slow-acting drugs (SYSADOAs)/disease modifying anti-osteoarthrosis drugs (DMOADs) in the treatment of osteoarthrosis: what is the opinion of the different rheumatology/osteoarthritis societies in 2021?.
<em>Medical Research Archives, 10</em>(1).
doi:10.18103/mra.v10i1.2676